🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Non-resectable stage III non-small cell lung cancer is recommended for conc...
Status
Unknown
Location
Affiliated Hospital of Guizhou Medical University
Start Date
2019-09-01
Trial ID
NCT04284215
Treatments Being Tested
Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % o...
Status
Unknown
Location
Presidio Ospedaliero Spedali Civili di Brescia
Start Date
2013-11
Trial ID
NCT02099188
Cisplatin-based chemoradiation (CCRT) has been considered as the standard c...
Status
Unknown
Location
Nanjing Medical University Affiliated Suzhou Hospital
Start Date
2015-07-01
Trial ID
NCT03163979
Radiation therapy has become the preferred treatment for nasopharyngeal can...
Status
Completed
Location
Jiangsu Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT06244394
Treatments Being Tested
In this study, participants will be randomly assigned to either the experim...
Status
Not Yet Recruiting
Location
Department of Radiation Oncology, Sun Yat-sen University Cancer Center
Start Date
2025-05-06
Trial ID
NCT06861712
In this study patients will be treated with 6 weeks of radiation therapy pl...
Status
Active Not Recruiting
Location
Sibley Memorial Hospital
Start Date
2014-07-08
Trial ID
NCT02177578
Treatments Being Tested
Definitive chemoradiotherapy (CRT) is the standard treatment option for unr...
Status
Active Not Recruiting
Location
Mian Xi
Start Date
2022-09-15
Trial ID
NCT05520619
Treatments Being Tested
This randomized phase II trial studies how well dose-escalated photon inten...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-12-04
Trial ID
NCT02179086
Treatments Being Tested
The investigators of this study want to see if shortening the total treatme...
Status
Completed
Location
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Start Date
2017-08-24
Trial ID
NCT02970448
Treatments Being Tested
Cyclin D kinase 4 (CDK4) is a key regulator of the G1-S transition in the c...
Status
Unknown
Location
Faculty of Medicine, Ramathibodi Hospital
Start Date
2017-07-19
Trial ID
NCT03024489
Treatments Being Tested